共 79 条
[1]
Menter A(2008)Guidelines of care for the management of psoriasis and psoriatic arthritis: section 1. Overview of psoriasis and guidelines of care for the treatment of psoriasis with biologics J Am Acad Dermatol. 58 826-850
[2]
Gottlieb A(2005)Psoriasis N Engl J Med. 352 1899-1912
[3]
Feldman SR(2013)The biological rationale for use of vitamin D analogs in combination with corticosteroids for the topical treatment of plaque psoriasis J Drugs Dermatol. 12 e129-e137
[4]
Van Voorhees AS(2009)Guidelines of care for the management of psoriasis and psoriatic arthritis: section 3. Guidelines of care for the management and treatment of psoriasis with topical therapies J Am Acad Dermatol. 60 643-659
[5]
Leonardi CL(2012)Assessment and management of psoriasis: summary of NICE guidance BMJ. 345 e6712-2009
[6]
Gordon KB(2010)Topical treatment of psoriasis Expert Opin Pharmacother. 11 1999-496
[7]
Schön MP(2013)Adherence and patient satisfaction with topical treatment in psoriasis, and the use, and organoleptic properties of such treatments: a Delphi study with an expert panel and members of the Psoriasis Group of the Spanish Academy of Dermatology and Venereology Actas Dermosifiliogr. 104 488-1271
[8]
Boehncke W-H(2012)Topical drug delivery systems in dermatology: a review of patient adherence issues Expert Opin Drug Deliv. 9 1263-127
[9]
Segaert S(2016)Superior efficacy of calcipotriene and betamethasone dipropionate aerosol foam versus ointment in patients with psoriasis vulgaris: a randomized phase II study J Dermatol Treat. 27 120-41
[10]
Røpke M(2016)Fixed combination aerosol foam calcipotriene 0.005% (Cal) plus betamethasone dipropionate 0.064% (BD) is more efficacious than Cal or BD aerosol foam alone for psoriasis vulgaris: a randomized, double-blind, multicenter, three-arm, phase II study J Clin Aesthet Dermatol. 9 34-1477